(CAMT) Camtek - Ratings and Ratios
Inspection Systems, Metrology
CAMT EPS (Earnings per Share)
CAMT Revenue
Description: CAMT Camtek
Camtek Ltd. is a leading provider of inspection and metrology equipment for the semiconductor industry, catering to a diverse customer base including semiconductor manufacturers, outsourced semiconductor assembly and test, integrated device manufacturers, and wafer level packaging subcontractors. The companys product portfolio includes a range of innovative systems, such as Eagle-i, Eagle-AP, Golden Eagle, and Hawk, designed to address the complex challenges of advanced packaging and wafer inspection.
Notably, Camteks products leverage advanced technologies, including deep learning techniques for automatic defect classification, and offer 2D and 3D inspection and metrology capabilities. The companys MicroProf series, including MicroProf AP, MicroProf DI, and MicroProf FE, provide specialized metrology tools for various applications in the semiconductor manufacturing process. With a strong presence in the global semiconductor industry, Camteks revenue growth is closely tied to the demand for advanced packaging and wafer inspection solutions.
From a financial perspective, Camteks market capitalization stands at approximately $4.2 billion, with a forward P/E ratio of 29.33, indicating a relatively high growth expectation. The companys return on equity (RoE) is 24.08%, suggesting a strong ability to generate profits from shareholder equity. To further evaluate Camteks performance, key performance indicators (KPIs) such as revenue growth rate, gross margin, and operating expenses as a percentage of revenue can be monitored. For instance, a high gross margin would indicate Camteks ability to maintain pricing power and efficient manufacturing processes.
Additional KPIs that can be used to assess Camteks performance include its research and development (R&D) expenditure as a percentage of revenue, which can indicate the companys commitment to innovation and staying ahead of the competition. Furthermore, metrics such as accounts receivable turnover and inventory turnover can provide insights into Camteks operational efficiency and ability to manage its working capital. By analyzing these KPIs, investors can gain a more comprehensive understanding of Camteks financial health and growth prospects.
CAMT Stock Overview
| Market Cap in USD | 5,030m |
| Sub-Industry | Semiconductor Materials & Equipment |
| IPO / Inception | 2000-07-28 |
CAMT Stock Ratings
| Growth Rating | 72.2% |
| Fundamental | 67.0% |
| Dividend Rating | 1.0% |
| Return 12m vs S&P 500 | 18.2% |
| Analyst Rating | 4.56 of 5 |
CAMT Dividends
Currently no dividends paidCAMT Growth Ratios
| Growth Correlation 3m | 39.4% |
| Growth Correlation 12m | 27.5% |
| Growth Correlation 5y | 76.4% |
| CAGR 5y | 76.93% |
| CAGR/Max DD 3y (Calmar Ratio) | 1.22 |
| CAGR/Mean DD 3y (Pain Ratio) | 3.92 |
| Sharpe Ratio 12m | 1.16 |
| Alpha | 26.83 |
| Beta | 1.410 |
| Volatility | 52.48% |
| Current Volume | 427.8k |
| Average Volume 20d | 531.6k |
| Stop Loss | 112.3 (-5.6%) |
| Signal | 1.18 |
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (133.8m TTM) > 0 and > 6% of Revenue (6% = 28.3m TTM) |
| FCFTA 0.12 (>2.0%) and ΔFCFTA 2.58pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 121.5% (prev 122.8%; Δ -1.33pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.13 (>3.0%) and CFO 122.2m <= Net Income 133.8m (YES >=105%, WARN >=100%) |
| Net Debt (6.44m) to EBITDA (129.4m) ratio: 0.05 <= 3.0 (WARN <= 3.5) |
| Current Ratio 5.41 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (49.3m) change vs 12m ago 0.03% (target <= -2.0% for YES) |
| Gross Margin 49.57% (prev 47.36%; Δ 2.20pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 53.26% (prev 46.32%; Δ 6.94pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1505 (EBITDA TTM 129.4m / Interest Expense TTM 37.0k) >= 6 (WARN >= 3) |
Altman Z'' 6.85
| (A) 0.59 = (Total Current Assets 702.9m - Total Current Liabilities 130.0m) / Total Assets 974.7m |
| (B) 0.41 = Retained Earnings (Balance) 403.8m / Total Assets 974.7m |
| (C) 0.06 = EBIT TTM 55.7m / Avg Total Assets 885.5m |
| (D) 1.16 = Book Value of Equity 405.2m / Total Liabilities 348.3m |
| Total Rating: 6.85 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 67.03
| 1. Piotroski 6.0pt = 1.0 |
| 2. FCF Yield 2.34% = 1.17 |
| 3. FCF Margin 23.78% = 5.94 |
| 4. Debt/Equity 0.32 = 2.45 |
| 5. Debt/Ebitda 0.05 = 2.50 |
| 6. ROIC - WACC (= -4.16)% = -5.20 |
| 7. RoE 23.49% = 1.96 |
| 8. Rev. Trend 92.22% = 6.92 |
| 9. EPS Trend 5.88% = 0.29 |
What is the price of CAMT shares?
Over the past week, the price has changed by +1.96%, over one month by +35.73%, over three months by +35.27% and over the past year by +35.80%.
Is Camtek a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CAMT is around 155.54 USD . This means that CAMT is currently undervalued and has a potential upside of +30.74% (Margin of Safety).
Is CAMT a buy, sell or hold?
- Strong Buy: 6
- Buy: 2
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CAMT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 107.1 | -10% |
| Analysts Target Price | 107.1 | -10% |
| ValueRay Target Price | 177 | 48.8% |
Last update: 2025-10-11 05:01
CAMT Fundamental Data Overview
P/E Trailing = 40.4596
P/E Forward = 34.0136
P/S = 10.6651
P/B = 8.5724
P/EG = 2.2707
Beta = 1.41
Revenue TTM = 471.6m USD
EBIT TTM = 55.7m USD
EBITDA TTM = 129.4m USD
Long Term Debt = 198.5m USD (from longTermDebt, last quarter)
Short Term Debt = 4.42m USD (from shortTermDebt, last quarter)
Debt = 198.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.44m USD (from netDebt column, last quarter)
Enterprise Value = 4.79b USD (5.03b + Debt 198.5m - CCE 436.0m)
Interest Coverage Ratio = 1505 (Ebit TTM 55.7m / Interest Expense TTM 37.0k)
FCF Yield = 2.34% (FCF TTM 112.1m / Enterprise Value 4.79b)
FCF Margin = 23.78% (FCF TTM 112.1m / Revenue TTM 471.6m)
Net Margin = 28.36% (Net Income TTM 133.8m / Revenue TTM 471.6m)
Gross Margin = 49.57% ((Revenue TTM 471.6m - Cost of Revenue TTM 237.8m) / Revenue TTM)
Gross Margin QoQ = 50.77% (prev 51.05%)
Tobins Q-Ratio = 4.92 (Enterprise Value 4.79b / Total Assets 974.7m)
Interest Expense / Debt = 0.02% (Interest Expense 37.0k / Debt 198.5m)
Taxrate = 8.73% (3.22m / 36.9m)
NOPAT = 50.8m (EBIT 55.7m * (1 - 8.73%))
Current Ratio = 5.41 (Total Current Assets 702.9m / Total Current Liabilities 130.0m)
Debt / Equity = 0.32 (Debt 198.5m / totalStockholderEquity, last quarter 626.5m)
Debt / EBITDA = 0.05 (Net Debt 6.44m / EBITDA 129.4m)
Debt / FCF = 0.06 (Net Debt 6.44m / FCF TTM 112.1m)
Total Stockholder Equity = 569.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 13.72% (Net Income 133.8m / Total Assets 974.7m)
RoE = 23.49% (Net Income TTM 133.8m / Total Stockholder Equity 569.4m)
RoCE = 7.25% (EBIT 55.7m / Capital Employed (Equity 569.4m + L.T.Debt 198.5m))
RoIC = 6.62% (NOPAT 50.8m / Invested Capital 767.4m)
WACC = 10.79% (E(5.03b)/V(5.23b) * Re(11.21%) + D(198.5m)/V(5.23b) * Rd(0.02%) * (1-Tc(0.09)))
Discount Rate = 11.21% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.18%
[DCF Debug] Terminal Value 71.84% ; FCFE base≈95.7m ; Y1≈118.1m ; Y5≈201.4m
Fair Price DCF = 45.25 (DCF Value 2.07b / Shares Outstanding 45.7m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 5.88 | EPS CAGR: -55.61% | SUE: -4.0 | # QB: 0
Revenue Correlation: 92.22 | Revenue CAGR: 16.00% | SUE: 1.07 | # QB: 1
Additional Sources for CAMT Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle